Ambria Capital, LLC is a dynamic brand on a mission to empower early-stage companies in the mental health and technology sectors. They believe in supporting ambitious entrepreneurs who have the ability to transform markets and make a positive impact on millions of lives. With a focus on mental health and technology, Ambria Capital invests their own money and makes independent decisions to stay committed to their portfolio companies for as long as it takes.

They embrace risk and understand that uncertainty often leads to great investments with life-changing outcomes. Ambria Capital is driven by a shared mission and purpose, even before there is tangible proof of success. They are dedicated to making real impact and helping companies create change that meaningfully improves the lives of millions.

By investing in ventures that address our generation's most important issues, such as psychedelics, digital health, cryptocurrency, and cybersecurity, Ambria Capital proactively champions transformative solutions. They are at the forefront of the mental health revolution, where psychedelics have shown tremendous potential in clinical trials, outperforming traditional antidepressants. By supporting visionary entrepreneurs, Ambria Capital plays a vital role in facilitating the promise and progress of psychedelic-assisted therapies in mental healthcare